4
Changes in Ownership
Bolt Biotherapeutics, Inc. Filed Acc 0001193125-25-321146
Options or other derivatives
- President, CEO and CFO acquired 108,286 shares (grant or award)
- President, CEO and CFO returned 108,286 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Quinn William P. · President, CEO and CFO
Table II: Derivative
16 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2025-12-12 | Grant or award : show line 1 in the form Employee Stock Option (Right to Buy) | +7,614 | 7,614 | D |
| 2025-12-12 | Returned to the company : show line 2 in the form Employee Stock Option (Right to Buy) | −7,614 | 0 | D |
| 2025-12-12 | Grant or award : show line 3 in the form Employee Stock Option (Right to Buy) | +3,927 | 3,927 | D |
| 2025-12-12 | Returned to the company : show line 4 in the form Employee Stock Option (Right to Buy) | −3,927 | 0 | D |
| 2025-12-12 | Grant or award : show line 5 in the form Employee Stock Option (Right to Buy) | +5,000 | 5,000 | D |
| 2025-12-12 | Returned to the company : show line 6 in the form Employee Stock Option (Right to Buy) | −5,000 | 0 | D |
| 2025-12-12 | Grant or award : show line 7 in the form Employee Stock Option (Right to Buy) | +10,499 | 10,499 | D |
| 2025-12-12 | Returned to the company : show line 8 in the form Employee Stock Option (Right to Buy) | −10,499 | 0 | D |
Loading xslF345X05/ownership.xml…